DUBLIN /PRNewswire/ -- The "U.S. Skin Grafts Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The U.S. Skin Grafts market is expected to reach US$ 522.52 million by 2025 from US$ 293 million in 2017, Growing at a CAGR of 7.6% during the forecast period 2018 to 2025.

The major factors driving the growth of this market are increasing number of burns injuries, pressure ulcers and Skin infections, developments in Skin Grafting techniques and technological advances in dermatomes are boosting the growth of the US Skin Grafts market. On the other hand, side-effects of Skin Grafting may hinder the growth of the market.

The U.S. Skin Grafts market is segmented based on type into autologous, allogeneic, xenogeneic, prosthetic and isogeneic. In 2018, autologous is expected to dominate the U.S. Skin Grafts  market with 38.5% market share and is expected to reach USD 207.25 million by 2025, growing at the highest CAGR of 8.1% in the forecast period of 2018 to 2025.

The U.S. Skin Grafts market is segmented based on Grafts thickness into split-thickness, full-thickness, and composite Grafts. In 2018, split-thickness is expected to dominate the US Skin Grafts market with 47.9% market share and is expected to reach USD 254.38 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.

The U.S. Skin Grafts market is segmented based on application into burns, extensive wound, Skin cancer, and extensive Skin loss due to infection. In 2018, burns is expected to dominate the U.S. Skin Grafts  market with 46.7% market share and is expected to reach USD 251.53 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.

The U.S. Skin Grafts market is segmented based on equipment type into dermatome, general surgical instruments, consumables, and others. In 2018, dermatome is expected to dominate the US Skin Grafts market with 43.7% market share and is expected to reach USD 235.29 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.

Dermatome is further sub-segmented into electrical dermatomes, air-powdered dermatomes, knife dermatomes, and drum dermatomes. In 2018, electrical dermatomes is expected to dominate the U.S. Skin Grafts  market with 47.6% market share and is expected to reach USD 115.88 million by 2025, growing at the highest CAGR of 8.6% in the forecast period 2018 to 2025.

Knife dermatome is further sub-segmented into Watson Knife, Cobbett Knife, and Blair/Brown Knife. In 2018, Watson Knife is expected to dominate the US Skin Grafts market with 53.9% market share and is expected to reach USD 63.51 million by 2025, growing at the highest CAGR of 8.8% in the forecast period 2018 to 2025.

Drum dermatome is further sub-segmented into Padgett Dermatomes, and Reese Dermatomes. In 2018, Padgett Dermatomes is expected to dominate the U.S. Skin Grafts s market with 61.5% market share and is expected to reach USD 317.01 million by 2025, with a CAGR of 7.4% in the forecast period 2018 to 2025. However, Reese Dermatomes is expected to grow at the highest CAGR of 7.9% in the forecast period, to reach USD 205.51 million by 2025 from USD 112.51 million in 2017 in the forecast period 2018 to 2025.

The U.S. Skin Grafts market is segmented on the basis of end users into ambulatory surgical centers, hospitals, and dermatology clinics. In 2018, ambulatory surgical centers is expected to dominate the U.S. Skin Grafts  market with 53.2% market share and is expected to reach USD 282.82 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.

Key Players

  • Organogenesis Inc.
  • Integra LifeSciences Corporation
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Exsurco Medical, Inc.
  • Mallinckrodt
  • Nouvag
  • Tissue Regenix
  • Avita Medical

Key Topics Covered 

1 Introduction

2 Market Segmentation

3 Market Overview
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4 Executive Summary

5 Premium Insights
5.1 Increasing Number of Burns Injuries, Pressure Ulcers, Skin Infections, and Developments in Skin Grafting Techniques are Expected to Drive the Market

6 U.S. Skin Graft Market, By Type
6.1 Overview
6.2 Autologous
6.3 Isogeneic
6.4 Allogeneic
6.5 Xenogeneic
6.6 Prosthetic

7 U.S. Skin Graft Market, By Graft Thickness
7.1 Overview
7.2 Split-Thickness
7.3 Full-Thickness
7.4 Composite Graft

8 U.S. Skin Graft Market, By Application
8.1 Overview
8.2 Burns
8.3 Extensive Wound
8.4 Extensive Skin Loss Due To Infection
8.5 Skin Cancer

9 U.S. Skin Graft Market, By Equipment Type
9.1 Overview
9.2 Dermatome
9.3 General Surgical Instruments
9.4 Consumables
9.5 Others

10 U.S. Skin Graft Market, By End User
10.1 Overview
10.2 Hospitals
10.3 Dermatology Clinics
10.4 Ambulatory Surgical Centers

11 U.S. Skin Graft Market, Company Landscape

12 Company Profiles
12.1 Integra Lifesciences Corporation
12.2 Organogenesis Inc.
12.3 Zimmer Biomet
12.4 B. Braun Melsungen AG
12.5 Avita Medical
12.6 De Soutter Medical
12.7 Exsurco Medical, Inc.
12.8 Mallinckrodt
12.9 Nouvag
12.10 Surtex Instruments Limited
12.11 Tissue Regenix

For more information about this report visit https://www.researchandmarkets.com/research/7d5rjh/the_u_s_skin?w=5


Media Contact:

Research and Markets 
Laura Wood, Senior Manager 
press@researchandmarkets.com    

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com